Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 330 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Completed

Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0303）

NCT02388919

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Capital Medical University, Beijing Chest Hospital Beijing, Beijing Municipality, China
  • Chinese Academy of Medical Sciences Cancer Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
View all 40 locations
View Trial Details
Completed

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma

NCT00531284

Conditions
Adnexal Diseases, Blood Protein Disorders, Bronchial Neoplasms, +47 more
Locations
  • Pinnacle Oncology Scottsdale, Arizona, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung Cancer

NCT01858389

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Tower Hematology Oncology Medical Group Beverly Hills, California, United States
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • Georgetown University Hospital-Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Georgetown University Medical Center Department of Pharmacy, Research Washington D.C., District of Columbia, United States
View all 14 locations
View Trial Details
Completed

Erlotinib Treatment Beyond Progression in EGFR Mutant NSCLC

NCT02064491

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Helsinki University Hospital Espoo, Finland
  • Helsinki University Hospital Helsinki, Finland
  • Oulu University Hospital Oulu, Finland
  • Pori Central Hospital Pori, Finland
View Trial Details

Related conditions